Greg Kennelty

Individualized Treatment Is Needed for mCRC Subset

January 17, 2017

Article

CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.

Discussing the World Health Organization's New Brain Tumor Classification

January 13, 2017

Article

The World Health Organization (WHO) reclassified some types of brain cancers, giving a clearer outline on how to treat them.

Comparing Treatments in Breast Cancer Subsets

January 06, 2017

Article

Sibylle Loibl, M.D., Ph.D., discusses the GeparSepto trial and what it means for women with breast cancer.

Expert Discusses What Advances to Expect in Liver Cancer

October 12, 2016

Article

Michael Choti talks about what kind of advances can be expected in treating liver cancer, including PD-1 inhibitors and neoadjuvant treatment.

4 Questions With a Surgeon: How to Improve Treatment of Glioblastoma

September 27, 2016

Article

More advances, such as personalized approaches, still need to be made in treating glioblastoma, says Jennifer Moliterno Gunel, a brain surgeon from Yale.

3 Questions: The Impact of Tecentriq to Treat Patients With Advanced Bladder Cancer

September 19, 2016

Article

Tecentriq (atezolizumab) has been found to be non-toxic and has demonstrated a major survival advantage in patients with metastatic urothelial bladder cancer.

5 Questions With a Physician on Improving Treatment of Pancreatic Cancer

August 19, 2016

Article

Eileen O'Reilly discusses the current barriers in treating pancreatic cancer, as well as what she sees for the future of the disease.

Physician Discusses Connection Between Early Tumor Shrinkage and Survival in Colorectal Cancer

August 11, 2016

Article

Volker Heinemann says early tumor shrinkage may be a better predictor than progression-free survival in colorectal cancer.

Nintedanib, Immunotherapy: Physician Looks Ahead in Treatment of Colorectal Cancer

August 05, 2016

Article

CURE spoke with Axel Grothey about advances in the treatment of colorectal cancer.

Multigene Panel Testing Could Reveal Breast and Ovarian Cancer Risks

July 14, 2016

Article

Allison W. Kurian offers insight on using multigene panel testing to discover breast and ovarian cancer risks that may have otherwise went undetected.

Abemaciclib Looks Promising in Breast Cancer Subset Ahead of Phase 3 Trial

July 12, 2016

Article

A phase 2 study showed that abemaciclib may be a promising option for some patients with breast cancer.

Expert Reviews Importance of BRCA Testing in Ovarian Cancer

June 27, 2016

Article

Testing for BRCA mutations is an important step in developing the treatment plan for patients with breast cancer, says Leslie Randall.

Exploring the Next Steps for Immunotherapy in Kidney Cancer

June 03, 2016

Article

What are the next steps for immunotherapy in RCC? CURE spoke with Mark Ball to find out.

Role of Radiation Continues to Change in Elderly Patients With Breast Cancer

June 02, 2016

Article

The role of radiation continues to change for patients with breast cancer, especially for those over the age of 70, for whom radiation might not be the best option.

Analyzing the Present and Future of Immunotherapy for Melanoma

May 12, 2016

Article

Many advances have been made regarding immunotherapy to treat melanoma, and there is also more to come, says Antoni Ribas.

PARP Inhibitor's Approval Could Expand to Include Ovarian Cancer Patients Without BRCA Mutation

April 13, 2016

Article

Phase 3 studies are giving investigators hope that Lynparza (olaparib) will gain FDA approval for the treatment of ovarian cancer, according to Ursula A. Matulonis.